Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Arrhythmias

  Free Subscription


Articles published in J Cardiol

Retrieve available abstracts of 96 articles:
HTML format



Single Articles


    December 2023
  1. TOMSIC A, Meucci MC, de Jong AR, Braun J, et al
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2023 Dec 14:S0914-5087(23)00295-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    November 2023
  2. YAMAMOTO T, Nambu Y, Bo R, Morichi S, et al
    Electrocardiographic R wave amplitude in V6 lead as a predictive marker of cardiac dysfunction in Duchenne muscular dystrophy.
    J Cardiol. 2023;82:363-370.
    PubMed     Abstract available


  3. NARUMI T, Naruse Y, Miyajima K, Kaneko Y, et al
    Actual conditions of atrial septal lead implantation and the factors related to successful implantation.
    J Cardiol. 2023;82:371-377.
    PubMed     Abstract available


    October 2023
  4. WENG CJ, Li CH, Lin YJ, Chang SL, et al
    Skin Sympathetic Nerve Activity in Different Ablation Settings for Atrial Fibrillation.
    J Cardiol. 2023 Oct 12:S0914-5087(23)00247-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  5. HARA H, Kubo S, Nakajima Y, Matsumoto T, et al
    Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00240-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  6. NAKATSUKASA T, Ishizu T, Minami K, Kawamatsu N, et al
    Reverse remodeling of the tricuspid valve complex by sinus rhythm restoration after catheter ablation.
    J Cardiol. 2023;82:248-256.
    PubMed     Abstract available


    September 2023
  7. NAGASE T, Kikuchi T, Unno T, Arai R, et al
    Impedance-guided modified CLOSE protocol ablation can reduce ablation index necessary for pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2023 Sep 7:S0914-5087(23)00224-1. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    August 2023
  8. ECKMAN MH, Wise R, Knochelmann C, Mardis R, et al
    Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?
    J Cardiol. 2023 Aug 12:S0914-5087(23)00191-0. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  9. KHALID SI, Sathianathan S, Thomson KB, McGuire LS, et al
    5-year Stroke Rates in Nonvalvular Atrial Fibrillation after Watchman compared to Direct Oral Anticoagulants.
    J Cardiol. 2023 Aug 2:S0914-5087(23)00181-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  10. IMAMURA S, Miyata M, Tagata K, Yokomine T, et al
    Prognostic predictors in patients with cardiopulmonary arrest: A novel equation for evaluating the 30-day mortality.
    J Cardiol. 2023;82:146-152.
    PubMed     Abstract available


    July 2023
  11. YANO M, Egami Y, Kawanami S, Sugae H, et al
    Left atrial appendage peak flow velocity predicts improvement in mitral regurgitation after atrial fibrillation ablation.
    J Cardiol. 2023 Jul 19:S0914-5087(23)00165-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  12. OKAMOTO H, Miyake M, Hayashi A, Matsutani H, et al
    Differences in clinical and echocardiographic features and outcomes between atrial functional mitral regurgitation patients with and without posterior mitral leaflet bending.
    J Cardiol. 2023;82:22-28.
    PubMed     Abstract available


  13. NAKAGAWA S, Takahama H, Hoshino K, Yanagi Y, et al
    Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation.
    J Cardiol. 2023;82:8-15.
    PubMed     Abstract available


    June 2023
  14. KAWAKAMI H, Saito M, Fujisawa T, Nagai T, et al
    A cost-effectiveness analysis of remote monitoring after pacemaker implantation for bradycardia in Japan.
    J Cardiol. 2023 Jun 19:S0914-5087(23)00139-9. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  15. KITAHARA H, Yamashita D, Sato T, Suzuki S, et al
    Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention.
    J Cardiol. 2023 Jun 17:S0914-5087(23)00138-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    May 2023
  16. KATAOKA N, Imamura T
    Prognostic impact of xanthine oxidoreductase activity in patients with heart failure and atrial fibrillation.
    J Cardiol. 2023 May 24:S0914-5087(23)00115-6. doi: 10.1016/j.jjcc.2023.
    PubMed    


  17. HAMEED I, Malik S, Nusrat K, Siddiqui OM, et al
    Effect of vitamin D on postoperative atrial fibrillation in patients who underwent coronary artery bypass grafting: A systematic review and Meta-analysis.
    J Cardiol. 2023 May 24:S0914-5087(23)00113-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  18. TOGASHI I, Sato T
    Conduction system pacing: Current status and prospects.
    J Cardiol. 2023;81:413-419.
    PubMed     Abstract available


    April 2023
  19. SEGEV A, Maor E, Goldenfeld M, Itelman E, et al
    Atrial fibrillation in young hospitalized patients: clinical characteristics, predictors of new onset, and outcomes.
    J Cardiol. 2023 Apr 26:S0914-5087(23)00096-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    March 2023
  20. CHOW JK, Bagai A, Tan MK, Har BJ, et al
    Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF+PCI-II Program.
    J Cardiol. 2023 Mar 15:S0914-5087(23)00052-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  21. BUKHARI S, Khan B
    Prevalence of Ventricular Arrhythmias and Role of Implantable Cardioverter-Defibrillator in Cardiac Amyloidosis.
    J Cardiol. 2023 Mar 7:S0914-5087(23)00048-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  22. TERASAKA N, Spanopoulos D, Miyagoshi H, Kubo T, et al
    Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study.
    J Cardiol. 2023;81:316-322.
    PubMed     Abstract available


    February 2023
  23. MIYAZAKI Y, Yamagata K, Wakamiya A, Shimamoto K, et al
    Adding interactive face-to-face lectures to passive lectures effectively reduces radiation exposure during atrial fibrillation ablation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00044-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  24. YANO M, Egami Y, Kawanami S, Sugae H, et al
    Relationship between pre-procedural non-ischemic ST-segment depression and the clinical outcomes after catheter ablation in persistent atrial fibrillation patients.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00043-6. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  25. WATANABE K, Arimoto T, Watanabe T, Otaki Y, et al
    Prognostic impact of plasma xanthine oxidoreductase activity in patients with heart failure with atrial fibrillation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00042-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  26. LI M, Ma W, Fan F, Yi T, et al
    Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    J Cardiol. 2023 Feb 7:S0914-5087(23)00021-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  27. KATAOKA N, Imamura T, Uchida K, Koi T, et al
    Urgent catheter ablation in Japanese patients with mechanical circulatory supports suffering from refractory ventricular electrical storm.
    J Cardiol. 2023;81:229-235.
    PubMed     Abstract available


    January 2023
  28. WADA H, Miyauchi K, Suwa S, Miyazaki S, et al
    Impact of atrial fibrillation type (paroxysmal vs. non-paroxysmal) on long-term clinical outcomes: The RAFFINE registry subanalysis.
    J Cardiol. 2023 Jan 12:S0914-5087(22)00331-8. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available


  29. NAKAHARA S
    Catheter ablation of ventricular tachycardia associated with structural heart disease: Current status and perspectives.
    J Cardiol. 2023;81:57-62.
    PubMed     Abstract available


    December 2022
  30. GASSANOV N, Mutallimov M, Caglayan E, Erdmann E, et al
    ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator.
    J Cardiol. 2022;80:573-577.
    PubMed     Abstract available


    November 2022
  31. IKEDA T, Yamashita T, Akao M, Atarashi H, et al
    Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study.
    J Cardiol. 2022 Nov 22:S0914-5087(22)00282-9. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available


  32. UENO H, Imamura T, Tanaka S, Fukuda N, et al
    Left atrial appendage closure for stroke prevention in nonvalvular atrial fibrillation: A current overview.
    J Cardiol. 2022 Nov 15. pii: S0914-5087(22)00277.
    PubMed     Abstract available


  33. CHEN WT, Li CH, Chou YH, Lin WL, et al
    Post-ablation augmentation of skin sympathetic nerve activity predicts a poor outcome of idiopathic ventricular arrhythmias.
    J Cardiol. 2022 Nov 10. pii: S0914-5087(22)00274.
    PubMed     Abstract available


    October 2022
  34. LEIVA O, Jenkins A, Rosovsky RP, Leaf RK, et al
    Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation.
    J Cardiol. 2022 Oct 29. pii: S0914-5087(22)00269.
    PubMed     Abstract available


  35. DING L, Weng S, Zhang H, Yu F, et al
    Novel tissue-pressure sensing technology using a wide-band dielectric imaging system: An in vivo study.
    J Cardiol. 2022;80:319-324.
    PubMed     Abstract available


  36. NIEHUES P, Wegner FK, Wolfes J, Willy K, et al
    Incidence and predictors of cardiac arrhythmias in patients with COVID-19 induced ARDS.
    J Cardiol. 2022;80:298-302.
    PubMed     Abstract available


    September 2022
  37. PATSIOU V, Samaras A, Kartas A, Moysidis DV, et al
    Prognostic implications of adherence to OACs among patients with atrial fibrillation: Insights from MISOAC-AF trial.
    J Cardiol. 2022 Sep 27. pii: S0914-5087(22)00241.
    PubMed     Abstract available


  38. HATORI Y, Sakai H, Hatori N, Kunishima T, et al
    Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry.
    J Cardiol. 2022 Sep 12. pii: S0914-5087(22)00220.
    PubMed     Abstract available


    August 2022
  39. MATSUDA S, Kato T, Morimoto T, Taniguchi T, et al
    Atrial fibrillation in patients with severe aortic stenosis.
    J Cardiol. 2022 Aug 23. pii: S0914-5087(22)00206.
    PubMed     Abstract available


  40. AKAO M, Tsuji H, Kusano K, Matsui K, et al
    Clinical characteristics and outcomes of Japanese atrial fibrillation patients with poor medication adherence: A sub-analysis of the GENERAL study.
    J Cardiol. 2022 Aug 16. pii: S0914-5087(22)00200.
    PubMed     Abstract available


  41. KOIZUMI T, Kamada R, Watanabe M, Yokoshiki H, et al
    Predictors of cardiovascular mortality after an electrical storm in patients with structural heart disease.
    J Cardiol. 2022;80:167-171.
    PubMed     Abstract available


    July 2022
  42. YAMAZAKI K, Ishida Y, Sasaki S, Toyama Y, et al
    Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
    J Cardiol. 2022 Jul 25. pii: S0914-5087(22)00160.
    PubMed     Abstract available


    June 2022
  43. INOUE H, Yamashita T, Akao M, Atarashi H, et al
    Corrigendum to 'Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry' [Journal of Cardiology 72 (2018) 300-306].
    J Cardiol. 2022 Jun 29. pii: S0914-5087(22)00154.
    PubMed    


  44. HEMMI H, Kataoka N, Imamura T
    Paroxysmal atrial fibrillation as a cause of unexplained syncope.
    J Cardiol. 2022 Jun 17. pii: S0914-5087(22)00139.
    PubMed    


  45. YAMASHITA T, Uchiyama S, Atarashi H, Okumura K, et al
    Treatment strategy of dabigatran etexilate following the availability of idarucizumab in Japanese patients with non-valvular atrial fibrillation: J-Dabigatran Surveillance 2.
    J Cardiol. 2022 Jun 15. pii: S0914-5087(22)00096.
    PubMed     Abstract available


  46. FUKUNAGA M, Isotani A, Shirai S, Murakami N, et al
    Initial practice of left atrial appendage closure device in Japan; single-center experience.
    J Cardiol. 2022;79:752-758.
    PubMed     Abstract available


    April 2022
  47. VARNEY JA, Dong VS, Tsao T, Sabir MS, et al
    COVID-19 and arrhythmia: An overview.
    J Cardiol. 2022;79:468-475.
    PubMed     Abstract available


  48. KUNO T, Takahashi M, So M, Egorova NN, et al
    The association of anticoagulation before admission and survival of patients with COVID-19.
    J Cardiol. 2022;79:489-493.
    PubMed     Abstract available


    March 2022
  49. MIYAZAKI S, Miyauchi K, Hayashi H, Yamashiro K, et al
    Trends of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the RAFFINE registry.
    J Cardiol. 2022 Mar 25. pii: S0914-5087(22)00058.
    PubMed     Abstract available


  50. CHEN WT, Lo LW, Tsai WC, Lin YJ, et al
    Application of dynamic display technology to identify gaps after pulmonary vein isolation in catheter ablation of atrial fibrillation.
    J Cardiol. 2022 Mar 23. pii: S0914-5087(22)00052.
    PubMed     Abstract available


  51. MIYAZAKI Y, Yamagata K, Ishibashi K, Inoue Y, et al
    Paroxysmal atrial fibrillation as a predictor of pacemaker implantation in patients with unexplained syncope.
    J Cardiol. 2022 Mar 12. pii: S0914-5087(22)00049.
    PubMed     Abstract available


  52. OGURA S, Nakamura K, Morita H, Nakagawa K, et al
    Fragmented QRS as a predictor of cardiac events in patients with cardiac sarcoidosis.
    J Cardiol. 2022;79:446-452.
    PubMed     Abstract available


    February 2022
  53. YAMANE T
    Catheter ablation of atrial fibrillation: Current status and near future.
    J Cardiol. 2022 Feb 24. pii: S0914-5087(22)00025.
    PubMed     Abstract available


  54. MORI H, Fukui K, Maeda A, Akashi Y, et al
    Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry.
    J Cardiol. 2022 Feb 22. pii: S0914-5087(22)00029.
    PubMed     Abstract available


  55. KIDA K, Nabeta T, Ishida M, Shiono T, et al
    D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
    J Cardiol. 2022 Feb 8. pii: S0914-5087(22)00015.
    PubMed     Abstract available


  56. OUCHI K, Sakuma T, Higuchi T, Yoshida J, et al
    Filling defects in the left atrial appendage restricted to the early phase of cardiac computed tomography as a potential risk of left atrial appendage dysfunction.
    J Cardiol. 2022;79:211-218.
    PubMed     Abstract available


  57. NAKAJIMA Y
    Effectiveness and safety of transcatheter left atrial appendage closure.
    J Cardiol. 2022;79:186-193.
    PubMed     Abstract available


    January 2022
  58. CHEN JY, Chen TW, Lu WD
    The HAT2CH2 score predicts neurologic events in patients with cardiac implantable electronic devices without atrial fibrillation.
    J Cardiol. 2022 Jan 8. pii: S0914-5087(21)00385.
    PubMed     Abstract available


  59. MIYAZAKI A, Uemura H
    Perspective of preexcitation induced cardiomyopathy; early septal contraction, and subsequent rebound stretch.
    J Cardiol. 2022;79:30-35.
    PubMed     Abstract available


    December 2021
  60. TAKEUCHI D, Uto K, Inai K, Nagashima Y, et al
    Prominent atrial fibrosis and its correlation with dilated atrium atrial tachyarrhythmia and long after classic Fontan surgery.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00360.
    PubMed     Abstract available


  61. KURAOKA A, Ishizu T, Sato M, Igarashi M, et al
    Left atrial regional strain assessed by novel dedicated three-dimensional speckle tracking echocardiography.
    J Cardiol. 2021;78:517-523.
    PubMed     Abstract available


    November 2021
  62. VALLES E, Marti-Almor J, Grau N, Casteigt B, et al
    Influence of PACE score and conduction disturbances in the incidence of early new onset atrial fibrillation after typical atrial flutter ablation.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00288.
    PubMed     Abstract available


  63. WANG Y, Shao C, Qi L, Tan J, et al
    EphrinB2-RhoA upregulation attenuates sympathetic hyperinnervation and decreases the incidence of ventricular arrhythmia after myocardial infarction.
    J Cardiol. 2021 Nov 5. pii: S0914-5087(21)00290.
    PubMed     Abstract available


  64. BICCIRE FG, Pastori D, Torromeo C, Acconcia MC, et al
    Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes.
    J Cardiol. 2021;78:368-374.
    PubMed     Abstract available


  65. LAO N, Lim J, Bashir H, Mahalwar G, et al
    Incidence of Atrioventricular Blocks and its Association with In-Hospital Mortality and Morbidity in Patients with Coronavirus Disease 2019.
    J Cardiol. 2021 Nov 1. pii: S0914-5087(21)00305.
    PubMed     Abstract available


    October 2021
  66. NAGANO T, Yasuoka R, Tanaka M, Maruyama M, et al
    A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 29. pii: S0914-5087(21)00244.
    PubMed     Abstract available


  67. OBAYASHI Y, Miyake M, Amano M, Kitai T, et al
    Impact of mitral versus aortic bioprosthetic valve position on thromboembolism and bleeding risk in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 26. pii: S0914-5087(21)00273.
    PubMed     Abstract available


  68. TU T, Li B, Li X, Zhang B, et al
    Dietary omega-3 fatty acids reduced atrial fibrillation vulnerability via attenuating myocardial endoplasmic reticulum stress and inflammation in a canine model of atrial fibrillation.
    J Cardiol. 2021 Oct 23. pii: S0914-5087(21)00207.
    PubMed     Abstract available


  69. WEI F, Ren W, Zhang X, Wu P, et al
    miR-425-5p is negatively associated with atrial fibrosis and promotes atrial remodeling by targeting CREB1 in atrial fibrillation.
    J Cardiol. 2021 Oct 20. pii: S0914-5087(21)00253.
    PubMed     Abstract available


  70. FUKUSHIMA S, Suzuki K, Kawamoto N, Kakuta T, et al
    Launching minimally invasive stand-alone maze procedure for atrial fibrillation.
    J Cardiol. 2021 Oct 5. pii: S0914-5087(21)00256.
    PubMed     Abstract available


  71. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.
    PubMed    


    September 2021
  72. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    PubMed     Abstract available


  73. KATO A, Sato J, Yoshii K, Yoshida S, et al
    The mid-term outcome of Fontan conversion compared with primary total cavopulmonary connection.
    J Cardiol. 2021;78:213-218.
    PubMed     Abstract available


    August 2021
  74. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    PubMed     Abstract available


  75. UKITA K, Egami Y, Kawamura A, Nakamura H, et al
    Clinical impact of very early recurrence of atrial fibrillation after radiofrequency catheter ablation.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00199.
    PubMed     Abstract available


    July 2021
  76. TOHOKU S, Bordignon S, Chen S, Bologna F, et al
    Validation of lesion durability following pulmonary vein isolation using the new third-generation laser balloon catheter in patients with recurrent atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00167.
    PubMed     Abstract available


  77. LAI SW
    Urine dipstick proteinuria and atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00179.
    PubMed    


  78. SAIRAKU A, Morishima N, Amioka M, Maeda J, et al
    Does atrial fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era.
    J Cardiol. 2021 Jul 10. pii: S0914-5087(21)00165.
    PubMed     Abstract available


    June 2021
  79. RAMESH T, Lee PYK, Mitta M, Allencherril J, et al
    Intravenous magnesium in the management of rapid atrial fibrillation: A systematic review and meta-analysis.
    J Cardiol. 2021 Jun 20. pii: S0914-5087(21)00151.
    PubMed     Abstract available


  80. TAKAHIRA H, Kajiyama T, Kondo Y, Nakano M, et al
    Pathophysiological background and prognosis of common atrial flutter in non-elderly patients: Comparison to Atrial Fibrillation.
    J Cardiol. 2021 Jun 14. pii: S0914-5087(21)00132.
    PubMed     Abstract available


  81. IMAMURA T
    Cardiac reverse remodeling following catheter ablation of atrial fibrillation.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00134.
    PubMed    


  82. KUSUNOSE K, Takahashi H, Nishio S, Hirata Y, et al
    Predictive value of left atrial function for latent paroxysmal atrial fibrillation as the cause of embolic stroke of undetermined source.
    J Cardiol. 2021 Jun 9. pii: S0914-5087(21)00129.
    PubMed     Abstract available


  83. IWANO T, Toda H, Nakamura K, Shimizu K, et al
    Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00113.
    PubMed     Abstract available


  84. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available


  85. ABE Y, Takahashi Y, Shibata T
    A new disease entity: Atrial functional mitral regurgitation.
    J Cardiol. 2021;77:565-569.
    PubMed     Abstract available


    May 2021
  86. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed     Abstract available


    April 2021
  87. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    PubMed     Abstract available


  88. OKISHIGE K, Yamauchi Y, Nagase S, Kusano K, et al
    Transcatheter cryo-ablation of septal accessory pathways, multicenter observational study in Japan.
    J Cardiol. 2021;77:380-387.
    PubMed     Abstract available


  89. ASHER E, Abu-Much A, Bragazzi NL, Younis A, et al
    CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.
    J Cardiol. 2021;77:375-379.
    PubMed     Abstract available


  90. TOPAZ G, Ben-Zvi E, Pereg D, Kitay-Cohen Y, et al
    Prediction of acute-coronary-syndrome using newly-defined R2-CHA2DS2-VASc score among patients with chest pain.
    J Cardiol. 2021;77:370-374.
    PubMed     Abstract available


    March 2021
  91. INOUE K, Hirao K, Kumagai K, Kimura M, et al
    Long-term efficacy and safety of anticoagulation after atrial fi brillation ablation: data from the JACRE registry.
    J Cardiol. 2021;77:263-270.
    PubMed     Abstract available


    February 2021
  92. WILLY K, Dechering DG, Reinke F, Bogeholz N, et al
    The ECG in sarcoidosis - a marker of cardiac involvement? Current evidence and clinical implications.
    J Cardiol. 2021;77:154-159.
    PubMed     Abstract available


  93. KISHIMA H, Mine T, Fukuhara E, Ishihara M, et al
    Left ventricular stiffness assessed by diastolic Wall strain predicts asymptomatic atrial high-rate episodes in patients with pacemaker implantation.
    J Cardiol. 2021;77:195-200.
    PubMed     Abstract available


  94. CHEN JY, Lu WD
    Duration of atrial high-rate episodes and CHA2DS2-VASc score to predict cardiovascular and cerebrovascular events in patients with dual chamber permanent pacemakers.
    J Cardiol. 2021;77:166-173.
    PubMed     Abstract available


    August 2020
  95. MIZOBUCHI A, Osawa K, Tanaka M, Yumoto A, et al
    Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30274.
    PubMed     Abstract available


    May 2020
  96. WILLY K, Reinke F, Bogeholz N, Ellermann C, et al
    The role of entirely subcutaneous ICD systems in patients with dilated cardiomyopathy.
    J Cardiol. 2020;75:567-570.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.